In particular, the CCL2/CCR2 axis, the inhibition of the Ras/Raf/MAPK pathway, and the differential expression of miR-142, miR-146a, and miR-223 in tumor cells appear to play a critical role and have high clinical relevance. The gene discussed is CCL2; the disease is neoplasm.